Global  

AstraZeneca

British-Swedish pharmaceutical company

AstraZeneca    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biopharmaceutical company with its global headquarters in Cambridge, England. Its R&D is concentrated in Cambridge, Gaithersburg, Maryland, and Mölndal in Sweden. AstraZeneca has a portfolio of products for major disease areas including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation.

0
shares
ShareTweetSavePostSend
 

Sanofi eyes vaccine approval by early 2021 [Video]

Sanofi eyes vaccine approval by early 2021

French drugmaker Sanofi expects to get approval for the potential coronavirus vaccine it is developing with GlaxoSmithKline by the first half of next year. Francis Maguire reports.

Credit: Reuters Studio     Duration: 01:13Published
AstraZeneca shares down after report it approached Gilead [Video]

AstraZeneca shares down after report it approached Gilead

Shares in Britain's AstraZeneca opened lower on Monday after a report it had approached U.S. rival Gilead Sciences about a possible merger. Ciara Lee reports

Credit: Reuters Studio     Duration: 01:09Published
AstraZeneca to make billion COVID vaccine doses if tests succeed [Video]

AstraZeneca to make billion COVID vaccine doses if tests succeed

AstraZeneca expects to be able to deliver a billion doses of a possible COVID-19 vaccine this year and next if tests are successful, adding on Thursday it should shortly get results of an early stage..

Credit: Reuters Studio     Duration: 01:20Published

You Might Like


Corrupt Propositions: AstraZeneca and the Coronavirus Vaccine Drive

corrupt propositions: astrazeneca and the coronavirus vaccine drive
Putting your destiny into the hands of a drug company is much like seeking reassurances from an opportunistic pimp. The returns are bound to mixed, dressed up in deceptive language. The promises,..
WorldNews - Published

AstraZeneca agrees to supply Europe with 400 million doses of COVID-19 vaccine

AstraZeneca Plc has signed a contract with European governments to supply the region with its potential vaccine against the coronavirus, the British drugmaker's latest deal to pledge its drug to help..
Reuters - Published Also reported by •Reuters India

AstraZeneca agrees to make Covid-19 vaccine for Europe

astrazeneca agrees to make covid-19 vaccine for europe
Pharmaceutical giant AstraZeneca has struck a deal with Europe’s Inclusive Vaccines Alliance to supply up to 400 million doses of an experimental Covid-19 vaccine, as efforts to boost manufacturing..
WorldNews - Published

Astrazeneca wins coronavirus vaccine deal with Germany, France, Italy and the Netherlands

British drugmaker AstraZeneca Plc said on Saturday it signed a contract with Italy, Germany, France and the Netherlands to supply Europe with a vaccine against the coronavirus, with deliveries starting..
Reuters - Published

Italy, Germany, France and Netherlands sign contract with Astrazeneca for COVID vaccine

Italy, Germany, France and the Netherlands have signed a contract with Astrazeneca to supply European citizens with a vaccine against the coronavirus, Italy's health minister said on Saturday.
Reuters - Published

Exclusive: Europe to accelerate trials of gene-engineered COVID-19 vaccines - sources

European officials aim to speed up trials for coronavirus vaccines containing genetically modified organisms, two EU sources told Reuters, in a move that could help shots developed by companies like..
Reuters India - Published

AstraZeneca contacted Gilead over potential megamerger: Bloomberg News

Britain's AstraZeneca has approached U.S. rival Gilead Sciences about a possible merger to form one the world's largest drug companies, Bloomberg News reported on Sunday, citing people familiar with..
Reuters - Published

Coronavirus vaccine: AstraZeneca boosts potential supply to 2bn

The drugs giant says it can double the production of a potential vaccine after backing by Bill Gates.
BBC News - Published

India pledges $15 million to global vaccine alliance as AstraZeneca announces licensing deal with Serum Institute


IndiaTimes - Published

Human trials of British coronavirus vaccine to reach 10,000

Oxford University and AstraZeneca are recruiting around 10,000 adults and children in Britain for trials of an experimental coronavirus vaccine, a day after receiving U.S. backing worth up to $1.2..
Reuters - Published

$1.2 Billion From U.S. to Drugmaker to Pursue Coronavirus Vaccine

The Trump administration announced a grant to AstraZeneca, which has licensed a potential vaccine that is in trials by Oxford University.
NYTimes.com - Published

US pledges up to $1.2 billion to access 300 million doses of experimental COVID-19 vaccine

An experimental COVID-19 vaccine being developed at Oxford by AstraZeneca received a big order: $1.2 billion from the United States for 300 million doses.
USATODAY.com - Published

AstraZeneca’s quest for Covid-19 vaccine gets $1bn boost from US

astrazeneca’s quest for covid-19 vaccine gets $1bn boost from us
London — UK pharmaceuticals group AstraZeneca says it has secured more than $1bn from the US to help fund production of its coronavirus vaccine. AstraZeneca is partnering with the University of..
WorldNews - Published

U.S. secures 300 million doses of potential AstraZeneca COVID-19 vaccine

The United States has secured almost a third of AstraZeneca's one billion possible COVID-19 vaccine doses by pledging up to $1.2 billion, as the world's biggest powers scramble for medicinal supplies..
Reuters - Published

U.S. commits $1.2 billion to possible British COVID vaccine

The United States will pump up to $1.2 billion into developing AstraZeneca's potential COVID-19 vaccine and said on Thursday it would order 300 million doses, as the White House seeks solutions to the..
Reuters - Published

AstraZeneca to make billion COVID vaccine doses if tests succeed

AstraZeneca expects to be able to deliver a billion doses of a possible COVID-19 vaccine this year and next if tests are successful, adding on Thursday it should shortly get results of an early stage..
Reuters - Published

AbbVie-Allergan $63 billion deal aided by Nestle, AstraZeneca buys

U.S. drugmaker AbbVie's $63 billion tie-up with Allergan is getting help from Nestle and AstraZeneca buying up products the Irish-domiciled company is shedding to placate regulators.
Reuters - Published

AstraZeneca's combo lung disease therapy fails to win FDA approval

The U.S. Food and Drug Administration declined to approve AstraZeneca Plc's combination therapy to treat smoker's lung, the drugmaker said on Tuesday.
Reuters - Published